A PROVEN STEREOTACTIC RADIOSURGERY PLATFORM. QUALITY OUTCOMES.
CyberKnife’s precise delivery allows the expansion of stereotactic radiosurgery and stereotactic body radiation therapy treatments to indications not possible to treat on any other radiation therapy machine.
Update on Phase 3 Randomized PACE Trial Data with Dr. Nicholas van As Phase 3 Randomized Trial Data shows SBRT has similar acute safety profile
Watch this patient testimonial on the CyberKnife System treatment for Prostate Cancer
Read about two large prospective, multi-institutional and CyberKnife® System only clinical studies report excellent clinical outcomes at
five years post-treatment.
Summary of a prospective clinical study that shows Cyberknife performs effectively & comparability to Gamma Knife for treating Trigeminal Neuralgia, but with better patient comfort.
See how CyberKnife aided in effectively treating Mike “Bing” Crosby for prostate cancer.
Read a description and evaluation of deformable image registration using Accuray Precision software.
This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes